Invention Grant
- Patent Title: Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment
-
Application No.: US15699626Application Date: 2017-09-08
-
Publication No.: US10265325B2Publication Date: 2019-04-23
- Inventor: Alfred Maelicke
- Applicant: NEURODYN LIFE SCIENCES INC.
- Applicant Address: CA Charlottetown
- Assignee: Neurodyn Life Sciences Inc.
- Current Assignee: Neurodyn Life Sciences Inc.
- Current Assignee Address: CA Charlottetown
- Agency: Knobbe, Martens, Olson & Bear LLP
- Priority: EP05020721 20050922
- Main IPC: A61K31/55
- IPC: A61K31/55 ; C07D307/91 ; C07D405/12 ; C07D491/06 ; C07F9/6561
Abstract:
A method for the treatment of a neurodegenerative, psychiatric or neurological disease associated with a cholinergic deficit comprising administering GLN-1062 or a pharmaceutically acceptable salt thereof by nasal administration to a patient in need thereof.
Public/Granted literature
Information query
